GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.8535
+0.1235 (16.92%)
At close: May 6, 2026, 4:00 PM EDT
0.7540
-0.0995 (-11.66%)
Pre-market: May 7, 2026, 5:12 AM EDT
GlucoTrack Employees
GlucoTrack had 11 employees as of December 31, 2024. The number of employees increased by 5 or 83.33% compared to the previous year.
Employees
11
Change (1Y)
5
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,762,545
Market Cap
1.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 11 | 5 | 83.33% | 11 | 0 |
| Dec 31, 2023 | 6 | 3 | 100.00% | 6 | 0 |
| Dec 31, 2022 | 3 | -2 | -40.00% | 3 | 0 |
| Dec 31, 2021 | 5 | -6 | -54.55% | 5 | 0 |
| Dec 31, 2020 | 11 | 4 | 57.14% | 11 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 97 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
GCTK News
- 6 days ago - Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 15 days ago - Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 5 weeks ago - Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones - GlobeNewsWire
- 7 weeks ago - GlucoTrack Transcript: EGM 2026 - Transcripts
- 2 months ago - Glucotrack to Present at LSI USA '26 Medtech Innovation Summit - GlobeNewsWire
- 3 months ago - Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - GlobeNewsWire
- 4 months ago - Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - GlobeNewsWire